REVIER Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.93M

  • Investors
  • 4

REVIER Therapeutics General Information

Description

Developer of disease-modifying therapies designed to treat cardiometabolic diseases. The company develops orally available small molecules that selectively target class IIa HDACs to inhibit pathogenic enzymatic activity, enabling patients with heart failure and atherosclerotic cardiovascular disease to restore cardiometabolic health and improve long-term outcomes.

Contact Information

Website
revier.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nikola-Tesla-Straße 1
  • 69124 Heidelberg
  • Germany
+49 06221
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Nikola-Tesla-Straße 1
  • 69124 Heidelberg
  • Germany
+49 06221

REVIER Therapeutics Timeline

202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

REVIER Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 25-Aug-2026 $6.93M Completed Startup
1. Seed Round 01-Jun-2025 Completed Startup
To view REVIER Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

REVIER Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
High-Tech Gründerfonds Venture Capital Minority
Revier Invest Venture Capital Minority
VORNvc Venture Capital Minority
Khanu Management Venture Capital Minority
To view REVIER Therapeutics’s complete investors history, request access »

REVIER Therapeutics FAQs

  • When was REVIER Therapeutics founded?

    REVIER Therapeutics was founded in 2023.

  • Where is REVIER Therapeutics headquartered?

    REVIER Therapeutics is headquartered in Heidelberg, Germany.

  • What industry is REVIER Therapeutics in?

    REVIER Therapeutics’s primary industry is Biotechnology.

  • Is REVIER Therapeutics a private or public company?

    REVIER Therapeutics is a Private company.

  • What is REVIER Therapeutics’s current revenue?

    The current revenue for REVIER Therapeutics is .

  • How much funding has REVIER Therapeutics raised over time?

    REVIER Therapeutics has raised $6.93M.

  • Who are REVIER Therapeutics’s investors?

    High-Tech Gründerfonds, Revier Invest, VORNvc, and Khanu Management have invested in REVIER Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process